Evidence map›Paper›PMID 19138974›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2008

Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma.

Martin J Blaser

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2022
    Trial
  3. Article
  4. Review
  5. Article
  6. Exploring the inhibitory potential ofFrontiers in molecular biosciences · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The Possible Role ofFrontiers in oncology · 2019
    Review
  14. Article
  15. An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2017
    Article
  16. Gastric microbiota: tracing the culprit.Clujul medical (1957) · 2017
    Review
  17. Vaccine against Helicobacter pylori: Inevitable approach.World journal of gastroenterology · 2016
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Martin J BlaserDepartment of Medicine, New York University Langone Medical Center, New York, NY 10016, USA. Martin.Blaser@med.nyu.edu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaBiodiversityBiological EvolutionDeveloped CountriesDisease SusceptibilityEsophageal NeoplasmsHelicobacter InfectionsHelicobacter pyloriHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.